BSE: JBCHEPHARM - J. B. Chemicals & Pharmaceuticals Limited

六个月盈利: -20.19%
股息率: +0.73%

促销时间表 J. B. Chemicals & Pharmaceuticals Limited


关于公司 J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI.

更多详情
It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

ISIN INE572A01028
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.6872
Дивиденд ао 15.25
Сайт https://www.jbpharma.com
Цена ао 1518
每周价格变化: -3.77% (1577.4)
每月价格变化: -6.72% (1627.3)
3个月内价格变化: -17.54% (1840.85)
六个月内的价格变化: -20.19% (1902)
每年价格变化: -2.02% (1549.25)
3年内价格变化: -3.32% (1570.1)
5年内价格变化: +205.74% (496.5)
年初以来价格变化: -19.89% (1894.9)

低估

姓名 意义 年级
P/S 7.25 1
P/BV 8.55 1
P/E 45.21 3
EV/EBITDA 5.46 9
全部的: 5.13

效率

姓名 意义 年级
ROA, % 14.64 4
ROE, % 20.45 7
全部的: 6.33

股息

姓名 意义 年级
Div yield, % 0.729 1.83
DSI 0.8571 8.57
全部的: 3.75

责任

姓名 意义 年级
Debt/EBITDA 0.124 10
全部的: 9.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 97.83 9
盈利能力 Ebitda, % 731 10
盈利能力 EPS, % 106.67 10
全部的: 9.8

导师 职称 支付 出生年份
Mr. Nikhil Ashokkumar Chopra CEO & Whole-Time Director 65.45M 1973 (52 年)
Mr. Kunal Khanna President of Operations N/A 1980 (45 年)
Mr. Sridhar Bharadwaj Vice President of HR & Administration N/A 1967 (58 年)
Mr. Pradeep Kumar Singh President of Global Business N/A 1964 (61 年)
Mr. Himanshu Ranvah Vice President of Legal N/A 1985 (40 年)
Mr. Parmeshwar B. Bang Executive Vice President of Operations of Daman N/A 1968 (57 年)
Suresh Amin Assistant Vice President ? Human Resource
Mr. Narayan Saraf Chief Financial Officer 1980 (45 年)
Mr. Bhagwat Singh Deora Vice President of Finance & Accounts 1982 (43 年)
Mr. Suresh Bhise Vice President of Information & Technology 1966 (59 年)

地址: India, Mumbai, Cnergy IT Park - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.jbpharma.com